🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Endometrial Carcinoma (EC)

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer NCT06893861n/a1 site📍 Naples National Cancer Institute, Naples · Tests: Metabolomic profiling Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC NCT03463252Phase 2, Phase 31 site📍 Chengdu West China Second University Hospital · Tests: Progesterone, Mirena®, GnRH agonist Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer NCT07838207n/a1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies NCT05669430Phase 1, Phase 213 sites📍 Los Angeles📍 Denver📍 New Haven GV20 Therapeutics · Tests: GV20-0251, GV20-0251, GV20-0251 and Pembrolizumab [KEYTRUDA®], GV20-0251 and Pembrolizumab [KEYTRUDA®] A Study of Ivonescimab in People With Endometrial and Cervical Cancers NCT06925724Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Ivonescimab Study of GV20-0251 in Participants With Solid Tumor Malignancies NCT07070518Phase 1, Phase 23 sites📍 Beijing📍 Beijing📍 Shanghai GV20 Therapeutics · Tests: GV20-0251 TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC NCT06914297Phase 21 site📍 Shanghai Fudan University · Tests: TQB2450 injection + oral progestin Intrauterine Injection of Type III Collage in FST of EC/AEH NCT07377734Phase 21 site📍 Beijing Wang Jianliu · Tests: Recombinant Humanized Type III Collagen Lyophilized Fibers + High-dose Progestin, High-dose Progestin A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Chinese Participants With Primary Advanced or Recurrent Endometrial Cancer (EC) NCT07108270Phase 21 site📍 Jinan GlaxoSmithKline · Tests: Dostarlimab, Carboplatin, Paclitaxel
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy